Thursday, May 23, 2019 4:42:06 PM
they buy cheap shares regularly, we know that. Last years they bought on multiple notes offering and now were frontrunning the Warrants deal - that is certainly a good sign.
We only can't derive any form of timing here, as they do that regularly and we are still waiting.
(Now my long diary note about last 'developments')
(Edit: Sorry for tons of typos & grammar mistakes, tired - good night)
What else happened?
AS is now at 700M, so the offer could get through.
Today's TO amendment didn't notified us that any exercise went through yet. Maybe we see it June 12th, if its not extended.
SoS gave me a heads up, I am not only being bashed by longs, but now shorts as well - guess that is balance in life (o8>
I read about NP's answers regarding the 50/50 100 pts safety data and it did sound as if they are done - but he only said they had more new pts injected w/ 700mg than 50 and the other half from extension like 'a lot' and 'more'. Wonders why he then couldn't say when safety is done, NP is too shy to give clear and strong answers! But this debate doesn't seem to matter here at all now. However, thank you Misui for asking.
Samsung meeting may gives hope, I agree. But no deal yet.
The potential investments from a pharma could be helpful, but they are investments and no upfront payments. Meaning they might buy shares to participate.
Chine as a catalyst is currently off the table, we know that.
RP couldn't give an appropriate answer why they promised TNBC injection in January, but still haven't done it yet.
Of course, they did mention some procedure - but that should have been known back then already. So no news here either.
Market is dipping - even profitable companies - and my expectations is about this 26.67c deal seems to be realized.
Meaning retail is selling and may buyback via the TO, I hope they buy of course - otherwise this would be devastating.
Current general market sentiment seem to be: Sell, then think and maybe buy later, or not.
Volume is down on many stocks, only jumps up on new lows.
US policy broke the while markets, China trade WAR was seemingly the last kick to initiate the official bear market.
Good day & night.
We only can't derive any form of timing here, as they do that regularly and we are still waiting.
(Now my long diary note about last 'developments')
(Edit: Sorry for tons of typos & grammar mistakes, tired - good night)
What else happened?
AS is now at 700M, so the offer could get through.
Today's TO amendment didn't notified us that any exercise went through yet. Maybe we see it June 12th, if its not extended.
SoS gave me a heads up, I am not only being bashed by longs, but now shorts as well - guess that is balance in life (o8>
I read about NP's answers regarding the 50/50 100 pts safety data and it did sound as if they are done - but he only said they had more new pts injected w/ 700mg than 50 and the other half from extension like 'a lot' and 'more'. Wonders why he then couldn't say when safety is done, NP is too shy to give clear and strong answers! But this debate doesn't seem to matter here at all now. However, thank you Misui for asking.
Samsung meeting may gives hope, I agree. But no deal yet.
The potential investments from a pharma could be helpful, but they are investments and no upfront payments. Meaning they might buy shares to participate.
Chine as a catalyst is currently off the table, we know that.
RP couldn't give an appropriate answer why they promised TNBC injection in January, but still haven't done it yet.
Of course, they did mention some procedure - but that should have been known back then already. So no news here either.
Market is dipping - even profitable companies - and my expectations is about this 26.67c deal seems to be realized.
Meaning retail is selling and may buyback via the TO, I hope they buy of course - otherwise this would be devastating.
Current general market sentiment seem to be: Sell, then think and maybe buy later, or not.
Volume is down on many stocks, only jumps up on new lows.
US policy broke the while markets, China trade WAR was seemingly the last kick to initiate the official bear market.
Good day & night.
Recent CYDY News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:35:02 PM
- CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
- CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference • GlobeNewswire Inc. • 02/20/2026 01:30:00 PM
